Work

Cost-Effectiveness of Saxagliptin Versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

Year: 2016

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2016.08.216

Authors: S Gu, H Shao, Y Zeng, L Shi, H Dong

Institutions: Zhejiang University, Tulane University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2540121791

FWCI: 0.645

Cites:

Cited by: 1

Related to: 10